Disease: Post-COVID-19

Mischke

Germany
|
2023
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neurostimulation

HeijenbrokKal

The Netherlands
|
2020
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19

IAMPOCO

Germany
|
2023-2025
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Immunoadsorption

InvidiCO

Germany
|
2024-2025
  • Adults
  • General population
  • Elderly
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Vimida

ISARIC

Brazil Colombia France Gibraltar India Israel Italy Malaysia Norway Portugal Spain Sudan Ukraine United Kingdom
|
2020-2022
  • Adults
  • General population
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19

Jacobi

Germany
|
2023
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation

Kroemer

Germany
|
2024-2027
  • Adults
  • General population
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Rehabilitation
  • Neurostimulation

Kuhn

Germany
|
2022
  • General population
  • Paediatric
  • Non-hospital health centre
  • Telemedicine
  • SARS-CoV-2
  • Post-COVID-19

LCHydroxy

United Kingdom
|
2023-2024
  • Adults
  • General population
  • Elderly
  • Primary care
  • SARS-CoV-2
  • Post-COVID-19
  • Non pharmacological intervention
  • Hydroxy gas

Lehmann

Germany
|
2022-2024
  • Adults
  • General population
  • Hospital wide
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19

Leppert

Italy Spain Switzerland
|
2022-2024
  • Adults
  • General population
  • Elderly
  • Outpatient clinic
  • SARS-CoV-2
  • Post-COVID-19
  • Pharmacological intervention
  • Monoclonal antibodies
  • Temelimab

Liebich

Germany
|
2021
  • Adults
  • General population
  • Hospital wide
  • SARS-CoV-2
  • Post-COVID-19